Amanda-Louise Fenger Carlander

7PUBLICATIONS
22CO-AUTHORS
Oral and maxillofacial surgeryPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyDental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 26, 2025
The impact of COVID-19 on oropharyngeal squamous cell carcinoma patient demographics, management, and oncologic outcomes: a Danish retrospective cohort study.

Sofie Voss Hastrup, Amanda-Louise Fenger Carlander, Kathrine Kronberg Jakobsen

|May 31, 2025
Prognostic impact of p16 and HPV discordance in cancer of unknown primary: a systematic review and meta-analysis.

Clara H Pinborg, Amanda-Louise F Carlander, Joachim Hansen

|Jan 29, 2025
The impact of the COVID-19 pandemic on time to treatment in head and neck cancer management: a systematic review.

Malte Grumstrup Simonsen, Amanda-Louise Fenger Carlander, Kathrine Kronberg Jakobsen

|Jan 03, 2025
Long-term Effectiveness and Safety of Mesenchymal Stromal Cell Therapy for Radiation-Induced Hyposalivation in Head and Neck Cancer Survivors: A Randomized Phase II Trial.

Amanda-Louise Fenger Carlander, Kathrine Kronberg Jakobsen, Tobias Todsen

|Mar 05, 2024
Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.

Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Tobias Todsen

Pageof 2